Treatment of anemia associated with chronic kidney disease with the HIF prolyl hydroxylase inhibitor enarodustat: A review of the evidence
Author:
Affiliation:
1. Medical Affairs Department Torii Pharmaceutical Co. Ltd Tokyo Japan
2. Pharmaceutical Division Japan Tobacco Inc Tokyo Japan
3. Division of Nephrology, Department of Medicine Showa University School of Medicine Tokyo Japan
Funder
Torii Pharmaceutical
Publisher
Wiley
Subject
Nephrology,Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13820
Reference48 articles.
1. Association of Kidney Function With Anemia
2. Mechanisms of Anemia in CKD
3. The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long-term survival
4. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
5. The cardio‐renal anemia syndrome: does it exist?;Silverberg D;Nephrol Dial Transplant,2003
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Untargeted Detection of HIF Stabilizers in Doping Samples: Activity-Based Screening with a Stable In Vitro Bioassay;Analytical Chemistry;2023-12-20
2. Effect of the Phosphate Binder Sevelamer Carbonate on the Bioavailability of Enarodustat, an Oral Erythropoiesis Stimulating Agent;Clinical Pharmacology in Drug Development;2023-11-17
3. Evaluation of the Carcinogenic Potential of Enarodustat (JTZ-951), a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor, in 26-Week Tg.rasH2 Mouse Study and 2-Year Sprague-Dawley Rat Study;International Journal of Toxicology;2023-07-22
4. Evaluation of Drug–Drug Interaction Potential of Enarodustat (JTZ‐951) Using a Cytochrome P450 Probe Cocktail;Clinical Pharmacology in Drug Development;2023-06-02
5. Managing Anemia: Point of Convergence for Heart Failure and Chronic Kidney Disease?;Life;2023-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3